The global demand for Macular Degeneration Treatment Market is presumed to reach the market size of nearly USD 18.11 MN by 2028 from USD 10.22 MN in 2021 with a CAGR of 10.92% under the study period 2022 - 2028.
Macular degeneration treatment is used to treat eye disease and minimize the risks of developing chronic blindness. It is a type of eye disease that causes blur or vision loss in the centre of the visual field. Its treatment includes wet macular and dry macular degeneration. Macular degeneration treatment can assist in to slowing the progress of the disease and avoid severe loss of vision.
Market Dynamics
The rising prevalence of retinal disorders is expected to propel the macular degeneration treatment market forward. Moreover, the growing research and development investments and rising approvals for new drugs are key factors driving the market growth. The ever-increasing geriatric population, changing dietary patterns and the rising adoption of sedentary lifestyles are factors leading to macular degeneration. Additionally, the increasing use of smartphones, laptops, and television, which leads to prolonged and excessive screen time, is influencing the occurrence of the disorder. However, the high cost associated with the treatment will hinder market growth.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of macular degeneration treatment. The growth and trends of macular degeneration treatment industry provide a holistic approach to this study.
Market Segmentation
This section of the macular degeneration treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Type
- Dry Age-Related Macular Degeneration
- Wet Age-Related Macular Degeneration
By Stage Of Disease
- Early-Stage AMD
- Intermediate AMD
- Late-Stage AMD
By Route Of Administration
- Intravenous Route
- Intravitreal Route
By Sales Channel
- Ambulatory Surgical Centers
- Hospitals
- Other Sales Channels
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Macular Degeneration Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Macular Degeneration Treatment Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the macular degeneration treatment market include F Hoffmann-La Roche Ltd, Novartis AG, Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., and Pfizer Inc., among others. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.